PT Kino Indonesia Tbk

PT Kino Indonesia Tbk

IIDX:KINO
1,380.00
IDR
-40.00
(-2.82%)
158.23EPS
6.99P/E
1.50TMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
3,601.35
3,202.06
2,445.12
2,212.45
2,528.19
3,275.21
2,817.48
2,783.66
2,607.07
2,999.8
3,167.56
3,206.77
3,546.65
Basic EPS, GAAP
- -
112.15
233.65
126.42
77.29
105.1
364.31
79.59
73.53
-687.06
51.1
62.81
89.71
155.98
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
46.16
- -
37
25
27
57
103
24.29
10.38
0.73
22.73
33.44
- -
Book Value per Share
322.39
462.77
1,242.73
1,350.31
1,412.58
1,511.34
1,831.54
1,780.59
1,838.55
1,062.89
1,120.5
1,193.83
1,262.87
1,332.05
Tangible Book Value per Share
322.39
462.77
1,242.73
1,350.31
1,412.58
1,511.34
1,831.54
1,715.7
1,766.57
991.91
1,052.59
1,132.5
1,206.44
1,275.43
Basic Weighted Avg Shares
650
927
1,125
1,429
1,429
1,429
1,429
1,429
1,429
1,393
1,379
1,379
1,379
1,379
Sales/Revenue/Turnover
- -
3,339,386
3,603,848
3,493,029
3,160,637
3,611,694
4,678,869
4,024,971
3,976,656
3,631,451
4,136,182
4,367,489
4,421,550
4,890,194
Operating Margin (%)
- -
5.63
12.04
6.98
5.99
6.87
9.38
5.54
5.83
-14.06
5.25
4.45
4.82
6.06
Depreciation Expense
- -
- -
- -
17,838
18,637
17,692
23,131
51,082
68,179
70,434
61,959
63,492
54,489
51,652
Net Income, GAAP
- -
103,996
262,971
180,602
110,417
150,149
520,444
113,697
105,043
-957,026
70,463
86,599
123,698
215,074
Effective Tax Rate (%)
- -
24.92
21.95
17.42
22.18
25.09
18.94
15.9
20.8
- -
32.03
16.78
20.48
8.29
Profit Margin (%)
- -
3.11
7.3
5.17
3.49
4.16
11.12
2.82
2.64
-26.35
1.7
1.98
2.8
4.4
Working Capital
-143,321
-201,822
798,875
655,379
709,839
661,417
601,904
415,847
806,626
-247,164
-367,008
-616,923
-795,417
-782,979
LT Debt
53,706
70,438
87,578
48,008
20,323
4,125
145,988
373,819
963,431
1,085,579
773,387
462,274
186,331
131,600
Total Equity
461,192
662,385
1,776,629
1,952,072
2,055,171
2,186,900
2,702,862
2,614,062
2,688,443
1,533,820
1,618,730
1,650,361
1,746,342
1,842,941
Return on Invested Capital (%)
- -
13.15
17.16
8.21
5.48
6.73
16.83
4.47
4.23
- -
4.76
4.77
5.11
8.06
Return on Capital (%)
- -
13.92
17.07
9.59
6.2
7.11
18.01
5.55
5.2
- -
4.86
5.9
6.66
9.56
Return on Common Equity (%)
- -
18.54
21.59
9.75
5.59
7.19
21.8
4.41
4.06
-46.78
4.68
5.43
7.3
12.2

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,374,983
1,333,009
1,285,438
LT Borrowings
161,933
113,577
65,222
LT Finance Leases
24,398
21,032
66,378
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,379
1,379
1,379
Market Capitalization
1,923,452
1,613,218
1,502,913

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,580,518
1,743,503
1,750,536
Cash, Cash Equivalents & STI
123,751
142,394
183,956
Accounts Receivable, Net
975,908
1,090,938
1,002,216
Inventories
380,792
367,503
434,746
Total Current Liabilities
2,375,935
2,518,277
2,533,515
Payables & Accruals
- -
- -
- -
ST Debt
1,374,983
1,333,009
1,285,438
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.51%
-5.36%
5.82%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
-92.6%
-212.06%
42.84%
Sales/Revenue/Turnover
2.81%
2.17%
1.24%
Total Cash Common Dividend
- -
563.14%
47.13%

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,103,664
1,063,272
1,048,738
1,151,815
4,367,489
2025
1,127,347
1,032,633
- -
1,228,579
4,421,550
2026
1,256,024
1,372,957
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12.79
9.64
-4.43
44.8
62.81
2025
28.07
11.12
- -
35.07
89.71
2026
45.7
64.09
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
22.73
2025
- -
- -
- -
- -
33.44
2026
- -
- -
- -
- -
- -

Company Description

CEO
Harry Sanusi
Full Time Employees
4,520
Sector
Consumer non-durables
Industry
Household/Personal care
Address
Kino Tower Tangerang BT Indonesia 15143
IPO Date
Dec 11, 2015
Website
kino.co.id
Business
PT Kino Indonesia Tbk stands as a prominent Indonesian fast-moving consumer goods entity, dedicated to the production and global distribution of an extensive array of personal care items, diverse beverages, food products, pharmaceutical offerings, and pet nourishment. The company's vibrant personal care division encompasses a wide range of solutions, including haircare lines such as Ellips, Sasha, and Samantha, alongside oral care products like Sasha and Click. Skin health is addressed through Ovale and Ristra, while Sleek Baby caters to infant care. Its portfolio also features Abstract decoratives, Eskulin fragrances, feminine hygiene essentials like Resik V and Absolute, and specialized personal care for children under the B&B Kids, Eskulin Kids, and Master Kids banners. Master brand products serve men's grooming needs, with Evergreen supplying air fresheners and Sleek and Instance Hand Sanitizer providing hygiene solutions. The MAXLife, Perro, KUCINGKU, and JOJO brands cater to the pet food market. Beyond personal care, Kino Indonesia offers a significant selection of beverages, including cooling remedy drinks like Cap Kaki Tiga and Larutan Sejuk Segar. Health-focused options are available through the Cap Panda brand, while Panther provides energy drinks, and the Malee brand (via a joint venture) delivers canned fruits, coconut water, and various juices. The company's food segment delights consumers with confectionery items such as Kino Candy, Oplozz, Frenta Candy, and Chew Chew Ball candies, alongside Snack It and Kino Nastar snacks, and Segar Sari powdered drinks. In the pharmaceutical space, Kino presents herbal cough remedies, balms, headache relievers, and treatments for skin conditions under the Cap Kaki Tiga and Q-Life labels, complemented by herbal products from Dua Putri Dewi. Established in 1999 and headquartered in Tangerang, Indonesia, the enterprise consistently pursues strategic expansion, both domestically and internationally, leveraging its wide distribution network across Indonesia and into various global regions including Asia, the Middle East, Russia, and Africa. With "Innovation is Our DNA" as a core principle, Kino emphasizes continuous product development, meeting evolving consumer demands, and strengthening its position as a relevant and cherished brand across generations. Recent activities underscore this commitment, with brands like Eskulin celebrating milestones and receiving awards for innovative marketing, and Ristra Clinic broadening its services with wellness programs. The company also engages in community and environmental initiatives, reflecting its dedication to social and governance pillars. PT Kino Indonesia Tbk operates as a subsidiary of PT Kino Investindo.